how do glp-1 drugs work Receptor Agonists as Treatments for Type 2 Diabetes The Ultimate Guide to GLP-1:
Description
The NAION incidence was 20 events in the semaglutide group compared to 3 in the non-GLP-1 RA group
As part of our routine safety review process for Mounjaro (tirzepatide) and Zepbound (tirzepatide) we have ongoing discussions with regulators regarding potential safety topics, and we will continue to review data, including any data regarding ophthalmic issues
PSG759 and European Research Councils starting grant under the grant agreement no
Diabetes Care 46 (Suppl 1), S216S229 (2023)
